156 related articles for article (PubMed ID: 9643129)
21. Opportunistic infections update.
Proj Inf Perspect; 1998 Dec; (26):5-6. PubMed ID: 11366497
[TBL] [Abstract][Full Text] [Related]
22. Opportunistic infections and HIV.
Ioannidis J; Wilkinson D
Clin Evid; 2002 Jun; (7):717-37. PubMed ID: 12230699
[No Abstract] [Full Text] [Related]
23. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
24. Maraviroc: new drug. Multiple antiretroviral treatment failure: too soon to reach conclusions.
Prescrire Int; 2008 Jun; 17(95):98-101. PubMed ID: 18623908
[TBL] [Abstract][Full Text] [Related]
25. Advances in HIV/AIDS therapy.
Johnson SC; Gerber JG
Adv Intern Med; 2000; 45():1-40. PubMed ID: 10635044
[TBL] [Abstract][Full Text] [Related]
26. Drug interactions, toxicities, dosages: trials and tribulations and cocktails.
Crit Path AIDS Proj; 1998; (No 33):9-17. PubMed ID: 11366377
[TBL] [Abstract][Full Text] [Related]
27. Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy.
Reiser M; Salzberger B; Stiepel A; Hoetelmans R; Diehl V; Fätkenheuer G
Eur J Med Res; 1999 Feb; 4(2):54-8. PubMed ID: 10066640
[TBL] [Abstract][Full Text] [Related]
28. Tuberculosis in HIV-infected patients: a comprehensive review.
Aaron L; Saadoun D; Calatroni I; Launay O; Mémain N; Vincent V; Marchal G; Dupont B; Bouchaud O; Valeyre D; Lortholary O
Clin Microbiol Infect; 2004 May; 10(5):388-98. PubMed ID: 15113314
[TBL] [Abstract][Full Text] [Related]
29. Drug interactions between antineoplastic and antiretroviral therapies: Implications and management for clinical practice.
Mounier N; Katlama C; Costagliola D; Chichmanian RM; Spano JP
Crit Rev Oncol Hematol; 2009 Oct; 72(1):10-20. PubMed ID: 19070506
[TBL] [Abstract][Full Text] [Related]
30. Safety of lopinavir/ritonavir for the treatment of HIV-infection.
Vogel M; Rockstroh JK
Expert Opin Drug Saf; 2005 May; 4(3):403-20. PubMed ID: 15934849
[TBL] [Abstract][Full Text] [Related]
31. Nucleoside analogue-sparing strategy for the treatment of chronic HIV infection: potential interest and clinical experience.
Joly V; Yeni P
Antivir Ther; 2005; 10(1):29-40. PubMed ID: 15751761
[TBL] [Abstract][Full Text] [Related]
32. Emergencies in HIV--part 2.
Rewari BB; Purohit V; Chhabra RM; Bhagwan J
J Assoc Physicians India; 2008 Oct; 56():783-6. PubMed ID: 19263705
[TBL] [Abstract][Full Text] [Related]
33. Medications in the treatment of HIV: associated conditions.
Capaldini L
Clin Podiatr Med Surg; 1998 Apr; 15(2):241-8. PubMed ID: 9576052
[TBL] [Abstract][Full Text] [Related]
34. [Management of urological patients with HIV infection].
Zabirov KI; Maksimov VA; Borisik VI; Iarovoĭ SK; Prokhorov AV; Balykov IS
Urologiia; 2010; (2):6-10. PubMed ID: 20967988
[TBL] [Abstract][Full Text] [Related]
35. Treating hepatitis C in HIV-HCV coinfected patients.
Tossing G
Infection; 2002 Oct; 30(5):329-31. PubMed ID: 12420736
[TBL] [Abstract][Full Text] [Related]
36. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
37. [Drug interactions and their management in patients with human immunodeficiency virus infection].
Cabarcos Ortíz de Barrón A; Martínez Vázquez JM; Lorenzo Zúñiga V; Barrio Gómez E
An Med Interna; 1998 Mar; 15(3):157-62. PubMed ID: 9580413
[TBL] [Abstract][Full Text] [Related]
38. [HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy].
Jambroes M; Weverling GJ; Reiss P; Danner SA; Jurriaans S; ten Veen JH; van der Ende ME; Schutten M; Schneider MM; Schuurman R; Mulder JW; Kroes AC; Lange JM; de Wolf F;
Ned Tijdschr Geneeskd; 2001 Aug; 145(33):1591-7. PubMed ID: 11534377
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of possible drug-drug interactions between antiretroviral agents in different age groups in a section of the private health care sector setting in South Africa.
Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
J Clin Pharm Ther; 2008 Aug; 33(4):393-400. PubMed ID: 18613857
[TBL] [Abstract][Full Text] [Related]
40. Management of HIV infection. A 1995-96 overview for the clinician.
Henry K
Minn Med; 1995 Nov; 78(11):17-24. PubMed ID: 8531901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
